Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 21, 2025.

via HealthDay

MONDAY, July 21, 2025 -- Version nine of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control staging system (AJCC9V) human papillomavirus (HPV)-positive oropharyngeal carcinoma staging classification offers improved prognostication and management compared with the eighth edition (AJCC8E), according to a multicenter registry analysis published online July 8 in The Lancet Oncology.

Allen S. Ho, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues divided U.S. registry data from the National Cancer Database into derivation and validation cohorts in order to reappraise HPV-positive oropharyngeal carcinoma pathological staging. A total of 14,447 adult patients across 984 facilities in the United States met the inclusion criteria and were divided into a derivation cohort and validation cohort (7,768 and 6,679 patients, respectively); patients were followed for a median of 52.4 months.

The researchers found that with each additional metastatic lymph node, mortality risk increased (hazard ratio, 1.20), up to an optimal cutoff of 4.3 lymph nodes. The association of pathological extranodal extension (pENE) with increased mortality risk was confirmed in multivariable analysis (hazard ratio, 1.47); the extent of pENE (minor versus major) was not associated with significant prognostic changes. Optimized pN and pathological tumor-node-metastasis stage categories were derived and validated in adjusted hazard ratio approaches. Compared with AJCC8E, AJCC9V staging system showed superior hazard consistency, outcome prediction, and balance, but not hazard discrimination.

"The new staging will better inform clinicians and patients about a patient's prognosis and will minimize inconsistencies in the treatments patients are offered," Ho said in a statement. "Currently, a patient diagnosed as stage 1 might be offered surgery plus radiation and chemotherapy, while another stage 1 patient may be offered surgery alone. The new guidelines will help ensure each patient receives the most appropriate treatment."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-22 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords